Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator

Tissue plasminogen activator (tPA) thrombolysis continues to be the gold standard therapy for ischemic stroke. Due to the time-limited treatment window, within 4.5 h of stroke onset, and a variety of potentially deadly complications related to delayed administration, particularly hemorrhagic transfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Knecht, Talia, Borlongan, Cesar, dela Peña, Ike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187940/
https://www.ncbi.nlm.nih.gov/pubmed/30450415
http://dx.doi.org/10.4103/bc.bc_21_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187940/
https://www.ncbi.nlm.nih.gov/pubmed/30450415
http://dx.doi.org/10.4103/bc.bc_21_18

Ejemplares similares